Product Information
IMITREX 6 MG/0.5 ML CARTRIDGES is a brand product labeled by GlaxoSmithKline LLC, priced at $436.7971 per ML under NDC 00173047800. Its NADAC has been published 656 times since Nov 28, 2013.
FDA first approved this application on Dec 28, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the sumatriptan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
6 mg/.5mL
Manufacturer
GlaxoSmithKline LLCNDC
00173047800
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
SUMATRIPTAN SUCCINATEApproval Type
New Drug (NDA)
FDA Application
NDA020080FDA Approved
12/28/1992
TE Code
AB
On Market Since
1/27/1997
Pharmacological Classes
Price Statistics
The NADAC for IMITREX 6 MG/0.5 ML CARTRIDGES has been published 656 times since Nov 28, 2013, and over the history we have for it it has risen 128.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $436.7971 per ML |
|---|---|
| All-time high | $442.6790 (Jul 10, 2024) |
| All-time low | $191.4632 (Nov 28, 2013) |
| 52-week high | $437.5630 |
| 52-week low | $435.9192 |
| Median price | $385.8228 |
| Average price | $370.4125 |
| Largest weekly change | +15.0% (Dec 30, 2015) |
| Weeks tracked | 656 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
GlaxoSmithKline LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
sumatriptan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of IMITREX 6 MG/0.5 ML CARTRIDGES?
The current National Average Drug Acquisition Cost (NADAC) for IMITREX 6 MG/0.5 ML CARTRIDGES, manufactured by GlaxoSmithKline LLC, is $436.7971 per ML (NDC 00173047800), effective Sep 30, 2026.
How has the price of IMITREX 6 MG/0.5 ML CARTRIDGES changed over time?
Over the history we have for it, the NADAC for IMITREX 6 MG/0.5 ML CARTRIDGES has risen 128.1%. It has been tracked across 656 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for IMITREX 6 MG/0.5 ML CARTRIDGES?
Since Nov 28, 2013, the NADAC for IMITREX 6 MG/0.5 ML CARTRIDGES has ranged from a low of $191.4632 (Nov 28, 2013) to a high of $442.6790 (Jul 10, 2024), with a median of $385.8228 per ML.
Are there cheaper alternatives to IMITREX 6 MG/0.5 ML CARTRIDGES?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SUMATRIPTAN 6 MG/0.5 ML VIAL, is $14.9345 per ML — about 97% below IMITREX 6 MG/0.5 ML CARTRIDGES.
Who manufactures IMITREX 6 MG/0.5 ML CARTRIDGES?
IMITREX 6 MG/0.5 ML CARTRIDGES (NDC 00173047800) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.